ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentZugDalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug
DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of DalCor Pharmaceuticals is the development and research of medicines for the treatment of cardiovascular diseases, particularly through the application of precision medicine. The company focuses on developing therapies to combat the world's largest health burden, cardiovascular diseases.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug

✓ Offered4
Precision medicine for cardiovascular diseases
Precision medicine approach for post-acute coronary syndrome patients with the ADCY9 rs1967309 AA genotype, including dalcetrapib-based treatment concepts and companion genetic testing.
Dal-GenE-2 Clinical Trial
Phase III, double-blind, randomized placebo-controlled study evaluating dalcetrapib in 2,000 patients with recent acute coronary syndrome and the ADCY9 AA genotype.
dal-GenE Clinical Trial
Completed interventional cardiovascular outcomes trial assessing dalcetrapib in post-acute coronary syndrome patients with the ADCY9 rs1967309 AA genotype.
Dalcetrapib development
Development, manufacturing and marketing of dalcetrapib for patients with the ADCY9-AA genotype; clinical trial and accompanying genetic marker.
Trust & reputation

ranQ Trust Score of DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug scores 82.0 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.89.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug scores 68.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.68.64%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug by reviews, experience and specialisations.

Is this your company?

Claim the company profile of DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Baarerstrasse 2
6302 Zug

At a glance

Legal form
Foreign branch
UID
CHE-441.445.979
Founded
2015 · 11 years
Last commercial register change
September 28, 2022
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.73.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    SI
    Sarepta International Holdings GmbH
    Zug
    MO
    Milestone One AG
    Zug
    NC
    Novotech Clinical Research AG
    Zug
    GS
    G&L Scientific (Schweiz) GmbH
    Zug
    TA
    Trialize AG
    Zug
    AP
    Aphaia Pharma AG
    Zug
    AP
    Alexion Pharma GmbH
    Baar
    OT
    Orchard Therapeutics (Switzerland) GmbH
    Zug